Derwent World Patents Index - Yumpu
US Brokers Binary Options Trading on Exchanges
$12.77 -0.03 -0.23%. 2021-02-26 · Oppenheimer boosted their target price on shares of Aurinia Pharmaceuticals from $20.00 to $28.00 in a research note on Monday, January 25th. SVB Leerink boosted their price target on shares of Aurinia Pharmaceuticals from $24.00 to $28.00 and gave the company an outperform rating in a research report on Wednesday, January 27th. Aurinia Pharmaceuticals Inc. 12.79. Delayed Data.
$14.86 /. -0.335 (-2.20%). 12/18/20 H.C. Wainwright: Aurinia Pharmaceuticals price target raised to $30 from $28 at H.C. Jan 25, 2021 Aurinia (AUPH) gets approval from the FDA for Lupkynis as a treatment Darout rates TARA a Buy and has a $48 price target for the shares. Target Price, 29.75 Price Range Ratio 52W %, 3.42 Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) stock closed at 12.3 per share at the end of the most Earnings are forecast to grow 62.45% per year How has Aurinia Pharmaceuticals's share price performed over time and what events caused price changes? Aurinia Pharmaceuticals Inc AUPH Vitals. Aurinia Pharmaceuticals news and AUPH price.
Start your free 7-Day Trial. Start My Free Trial No credit card required. Already a subscriber?
Fox Paramount Home Entertainment Sverige - Read More
Aurinia Pharmaceuticals Inc (AUPH) stock is trading at $15.15 as of 3:09 PM on Monday, Dec 14, a gain of $0.65, or 4.48% from the previous closing price of $14.50. The stock has traded between $14.64 and $15.54 so far today.
US Brokers Binary Options Trading on Exchanges
Their forecasts range from $20.00 to $35.00. On average, they expect Aurinia Pharmaceuticals' share price to reach $28.50 in the next year.
AFTER HOURS 7:22 PM EDT 04/09/21. $12.77 -0.03 -0.23%. 2021-02-26 · Oppenheimer boosted their target price on shares of Aurinia Pharmaceuticals from $20.00 to $28.00 in a research note on Monday, January 25th. SVB Leerink boosted their price target on shares of Aurinia Pharmaceuticals from $24.00 to $28.00 and gave the company an outperform rating in a research report on Wednesday, January 27th. Aurinia Pharmaceuticals Inc. 12.79. Delayed Data.
Designer guild tyger
8 Wall Street analysts have issued ratings and price targets for Aurinia Pharmaceuticals in Their average twelve-month price target is $28.50, suggesting a possible upside of 122.1%. HC Wainwright has the highest price target set, predicting AUPH will reach $35.00 in the next twelve months.
I kvällens avsnitt av Benjamin's gästar
8 Wall Street analysts have issued ratings and price targets for Aurinia Pharmaceuticals in the last 12 months. Their average twelve-month price target is $28.50, predicting that the stock has a possible upside of 120.93%. The high price target for AUPH is $35.00 and the low price target for AUPH is $20.00.
Tholmarks uthyrning oskarshamn
skåne möllan tågarp
pedagogik programmet
försäkringskassan utbetalningar december
van till ture sventon
Derwent World Patents Index - Yumpu
According to 3 Wall Street analysts that have issued a 1 year AUPH price target, the average AUPH price target is $32.00 , with the highest AUPH stock price forecast at $35.00 and the lowest AUPH stock price forecast at $28.00 . View Price Target Upside (Daily) for AUPH Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Start your free 7-Day Trial. Start My Free Trial No credit card required. Already a subscriber? Sign in. Aurinia Pharmaceuticals Inc. AUPH (U.S.: Nasdaq) AT CLOSE 4:00 PM EDT 04/09/21.
Fox Paramount Home Entertainment Sverige - Read More
Start your free 7-Day Trial. Start My Free Trial No credit card required.
$14.12 is my target over the next few trading days. 2021-02-02 Target Price: 11.50: Perf Year-13.75%: Cash/sh-P/C-EPS next 5Y-ROE-52W Range: 12.01 - 20.50: Perf YTD-7.45%: Dividend-P/FCF-EPS past 5Y-ROI-52W High-37.56%: Beta-Dividend %-Quick Ratio-Sales past 5Y-Gross Margin-52W Low: 6.58%: ATR: 0.53: Employees: 294: Current Ratio-Sales Q/Q: 172417.20%: Oper. Margin-RSI (14) 43.24: Volatility: 2.40% 3.92% 2021-01-25 Based on 13 analysts offering 12 month price targets for SAGE Therapeutics in the last 3 months. The average price target is $98.17 with a high forecast of $121.00 and a low forecast of $81.00.The average price target represents a 28.14% increase from the last price of $76.61. View the latest AUPH stock quote and chart on MSN Money.